Abstract
BackgroundUraemic cardiomyopathy is present in >70% of patients with end-stage renal disease (ESRD). Myocardial fibrosis is a hallmark of uraemic cardiomyopathy and is associated with an increased risk of heart...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
